NCT05187819 · RECRUITING
Blood-based Biomarkers for Diagnosis of Alzheimer's
This trial is testing whether a simple blood test can accurately diagnose Alzheimer's disease in everyday primary care settings — at the regular GP level, not just in specialist research clinics. It is not a drug trial. Researchers want to know if blood biomarkers that work well in controlled studies hold up when used on real patients whose GP suspects dementia. This is a feasibility and accuracy study, not a treatment trial.
You may qualify if
- Participants suspected by their GP to have possible dementia, based on history, clinical examination and/or cognitive screening
You're excluded if
- Lack of capacity for consent as judged by the GP.
- Severe psychiatric disease, use of medication or physical disease that according to the GP may affect participation or likely contribute significantly to the observed cognitive impairment.
- Patients not wanting to be referred to the memory outpatient clinic.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2023-09-28